Top Pharmaceuticals companies in Switzerland by EBITDA Margin
Switzerland
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
76.56%
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 2 |
39.12%
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 3 |
34.95%
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 4 |
30.46%
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 5 |
29.50%
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 6 |
28.28%
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 7 |
23.71%
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 8 |
23.42%
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 9 |
22.81%
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 10 |
20.85%
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 11 |
19.13%
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 12 |
18.97%
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 13 |
18.12%
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 14 |
16.26%
|
Dec. 31, 2023 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 15 |
15.79%
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 16 |
15.67%
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 17 |
14.71%
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 18 |
14.67%
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 19 |
11.65%
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 20 |
9.81%
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 21 |
8.84%
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 22 |
8.59%
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 23 |
8.19%
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 24 |
7.74%
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 25 |
3.98%
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 26 |
-5.63%
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 27 |
-6.91%
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 28 |
-31.01%
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 29 |
-54.61%
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 30 |
-210.99%
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 31 |
-350.19%
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 32 |
-634.16%
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 33 |
-845.62%
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 34 |
-5,178.48%
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest EBITDA Margin ?
The Pharmaceuticals company in Switzerland with the highest EBITDA Margin is Santhera Pharmaceuticals Holding AG (Swiss Stock Exchange: SANN.SW) at 76.56%.
-
Which Pharmaceuticals company in Switzerland has the lowest EBITDA Margin ?
The Pharmaceuticals company in Switzerland with the lowest EBITDA Margin is Oculis Holding AG (NasdaqGM: OCS) at -5,178.48%.
-
What are the top 10 Pharmaceuticals companies in Switzerland by EBITDA Margin ?
The top 10 Pharmaceuticals companies in Switzerland by EBITDA Margin are Santhera Pharmaceuticals Holding AG, Novartis AG, Dottikon Es Holding AG, Roche Holding AG, Ypsomed Holding AG, Bachem Holding AG, Alcon Inc., Medacta Group SA, Lonza Group AG and Straumann Holding AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by EBITDA Margin ?
The bottom 10 Pharmaceuticals companies in Switzerland by EBITDA Margin are Oculis Holding AG, Molecular Partners AG, Addex Therapeutics Ltd, AC Immune SA, ADC Therapeutics SA, CRISPR Therapeutics AG, Kuros Biosciences AG, PolyPeptide Group AG, DocMorris AG and DKSH Holding AG.